Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione Reductase
Kei Hayashida(Northwell Health), Fumito Ichinose(Harvard University), Michael G. Silverman(Harvard University), Aranya Bagchi(Massachusetts General Hospital), Yusuke Miyazaki(Massachusetts General Hospital), Jonathan S. Stamler(Duke Medical Center), Divya Seth(University School), Eizo Marutani(Harvard University), Allyson G. Hindle, Shuichi Hirai(Nihon University), Lorenzo Berra(Massachusetts General Hospital), Michael W. Donnino, Rajeev Malhotra(Brigham and Women's Hospital), Xiaowen Liu(Beth Israel Deaconess Medical Center), Matthews O. Bradley(Behavioral Pharma (United States)), Emanuele Rezoagli(University of Milano-Bicocca), Naohiro Mori(Harvard University), Aurora Magliocca(University of Milan)
Cited by 66
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Part 9: Post–Cardiac Arrest Care
|Circulation|2010|2.5k
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
|JAMA|2016|1.5k
Part 8: Post–Cardiac Arrest Care
|Circulation|2015|1.2k
Part 1: Executive Summary
|Circulation|2015|713